[Endoscopic argon-plasma coagulation and combined radiotherapy for short (up to 3 cm) esophageal cancers].
The immediate and 3-year results were evaluated of application of combined radiotherapy and/or endoscopic argon-plasma coagulation carried out for esophageal cancers 3 cm long or less in 39 patients. Recurrences were reported, in 31.4% ca. 4 months later. Joint use of the modalities was followed by an up to 5-months rise in relapse-free period. Mean survival time was 20.2 months, and it was significantly higher in radiation-treated patients without metastases. One-year survival was 96.6% in those without distant metastases, 2-year--72%, and 3-year--47.6%. Our data point to new vistas in application of our techniques, particularly, for short (up to 3 cm) inoperable esophageal cancers.
Shcherbakov
A M
AM
Kanaev
S V
SV
Shulepov
A V
AV
D000328:Adult; D000368:Aged; D001128:Argon / Q000627:therapeutic use*; D004938:Esophageal Neoplasms / Q000473:pathology* / Q000532:radiotherapy*; D005260:Female; D006801:Humans; D017075:Laser Coagulation / Q000379:methods*; D008297:Male; D008875:Middle Aged; D011868:Radioisotopes / Q000627:therapeutic use*; D016019:Survival Analysis; D016896:Treatment Outcome
D011868:Radioisotopes; D001128:Argon